Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Feverfew (MIG-99) - Nutraceuticals World

What are you searching for?

Sign in
Research

Feverfew (MIG-99)

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Migraine

Source: Cephalalgia, November 2005; 25(11):1031-41.

Research: Researchers carried out a study in 170 migraine patients. At the start of the study, subjects were experiencing five attacks on average over a four-week period. The subjects were randomly assigned to receive MIG-99 three times a day or placebo for up to four months. The primary endpoint was the average number of migraine attacks per 28 days during the treatment months two and three compared with baseline.

Results: In the feverfew group, migraine frequency declined by two attacks per month. In the placebo patients, the corresponding decrease was only one per month. Researchers concluded that the feverfew preparation was 3.4 times more effective than placebo. They also deemed the benefit-risk ratio to be favorable.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters